Clinical trial NCT00161057: Functional Brain Activation Patterns in Schizophrenia, Measured Before and After Treatment
Official title: Functional Brain Activation Patterns in Schizophrenia, Measured Before and After Treatment
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Schizophrenia
Schizophreniform Disorders
Keywords: Schizophrenia
Medication-naive
Functional MRI
Working memory
Language lateralization
schizoaffective disorder
psychotic disorder Not Otherwise Specified
Lead sponsor: UMC Utrecht
Sponsor class: OTHER
First posted: 2005-09-12
Enrollment: 78
Sex: ALL
Minimum age (years): 16
Maximum age (years): 50
Standard ages: CHILD
ADULT
Accepts healthy volunteers: yes
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: PROBABILITY_SAMPLE
Study population: first episode schizophrenia patients, medication naive (or medication-free) and matched healthy controls.

Brief summary: In this study we, the investigators at UMC Utrecht, intend to investigate changes in brain activation patterns using functional magnetic resonance imaging (MRI), in patients suffering from schizophrenia who are medication naive or off medication, before using medication and after 8 weeks of medication. Patients will perform a working memory task, a language task and a motor task while lying in the scanner. We hypothesize that the efficiency of the working memory system is reduced and that the lateralization of language is diminished in these patients, and that these functions will normalize after treatment.

Detailed description: Schizophrenia is a heterogeneous disorder with a wide range of symptoms and signs including hallucinations, delusions, disorganisation, negative symptoms and cognitive deficits. Investigation of the neural substrates of the cognitive deficits in schizophrenia has revealed abnormalities in brain activity patterns. Particularly, earlier studies using functional FMRI conducted at the UMCU, revealed diminished language laterality, deficits in working memory and a reduced ability to automate cognitive processes. The aim of this project is to study the relationship between these brain activation patterns and neuroleptic treatment. More insight into psychopharmacological effects on brain physiology, may eventually enable us to better predict what effect treatment will have on patients.

Patients with a confirmed diagnosis of schizophrenia, schizophreniform disorder, schizoaffective disorder or psychotic disorder not otherwise specified (NOS), who are medication naive or medication free for a period of at least 2 weeks will be included. Patients will be tested before and after 8 weeks of treatment with an atypical antipsychotic. In the scanner patients will perform a working memory task, a language task and a visual-motor task. At study entry and after 8 weeks the PANSS, Clinical Global Impressions (CGI) and CDSS (Calgary Depression Scale of Schizophrenia) will be performed. Besides these patients, we will also include a group of matched healthy controls. We hypothesize that in medication naive or patients of-medication lateralization is reduced, and that efficiency of the working memory system is reduced. Lateralization is expected to correlate negatively with positive functions. We expect that antipsychotic treatment will normalize brain function and that the degree of normalization is correlated with the clinical measures of treatment efficacy.

Eligibility criteria: Inclusion Criteria (patients):

* Diagnoses of schizophrenia, schizophreniform disorder, schizoaffective disorder or psychotic disorder NOS, confirmed on the basis of Comprehensive Assessment of Symptoms and History (CASH) or a Structured Clinical Interview for DSM-IV Disorders (SCID) interview
* Ages between 16 and 50 years
* CGI of at least 4
* Patients are neuroleptic-naive or medication-free for at least 2 weeks

Inclusion Criteria (healthy controls):

* No psychiatric disorders (according to Diagnostic and Statistical Manual of Mental Disorders, 4th Edition \[DSM-IV\], Axis I)
* No psychiatric disorders in first degree relatives.
* Ages: between 18 and 50 years old

Exclusion Criteria (patients and healthy controls):

* Ferrous objects in or around the body
* Neurological or medical illness, including closed head injury.
* Mental retardation.
* Diagnosis of substance dependence within the previous 3 months.
* Pregnancy
* Treatment with antidepressants or mood stabilizers within 3 weeks of inclusion.

Primary outcomes:
Secondary outcomes:
Other outcomes:
Locations:
city: Utrecht
country: Netherlands
facility: Dept. of Psychiatry, UMC Utrecht
Study officials:
affiliation: UMC Utrecht
name: Nicoletta V Veelen
role: PRINCIPAL_INVESTIGATOR
affiliation: UMC Utrecht
name: Rene Kahn, M.D. Ph.D.
role: STUDY_CHAIR
References: